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Purpose: To examine the cerebrospinal fluid (CSF) dynamics along the entire optic nerve
in patients with idiopathic intracranial hypertension (IIH) and papilledema by computed
tomographic (CT) cisternography.
Methods: Retrospective analysis of CT cisternographies in 16 patients with a history
of IIH and papilledema (14 females and 2 males, mean age: 49 ± 16 years). Contrast
loaded CSF (CLCSF) was measured in Hounsfield Units (HU) at three defined regions
of interest (ROI) along the optic nerve (orbital optic nerve portion: bulbar and mid-orbital
segment, intracranial optic nerve portion) and additionally in the basal cistern. The density
measurements in ROI 1, ROI 2, and ROI 3 consist of measurements of the optic nerve
complex: optic nerve sheath, CLCSF filled SAS and optic nerve tissue. As controls served
a group of patients (mean age: 60 ± 19 years) without elevated intracranial pressure and
without papilledema.
Results: In IIH patients the mean CLCSF density in the bulbar segment measured 65
± 53 HU on the right and 63 ± 35 HU on the left side, in the mid-orbital segment 68 ±
37 HU right and 60 ± 21 HU left. In the intracranial optic nerve portion 303 ± 137 HU
right and 323 ± 169 HU left and in the basal cistern 623 ± 188 HU. Within the optic
nerve the difference of CLCSF density showed a highly statistical difference (p < 0.001)
between the intracranial optic nerve portion and the mid-orbital segment. CLCSF density
was statistically significantly (p< 0.001) reduced in both intraorbital optic nerve segments
in patients with IIH compared to controls.
Conclusions: The current study demonstrates reduced CLCSF density within the orbital
optic nerve segments in patients with IIH and papilledema compared to 12 controls
without elevated intracranial pressure and without papilledema. Impaired CSF dynamics
could be involved in the pathophysiology of optic nerve damage in PE in IIH.
Keywords: idiopathic intracranial hypertension, cerebrospinal fluid, optic nerve, optic canal, optic nerve sheath
compartment
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INTRODUCTION
Idiopathic intracranial hypertension (IIH) is a neurological
disorder characterized by elevated intracranial pressure (ICP)
in the absence of any known causative factor (mass lesion,
inflammation, central venous thrombosis). The patients typically
present with headache, visual disturbances (transient visual
obscurations), tinnitus and diplopia. Mainly affected are obese
women of childbearing age (1, 2). IIH can be self-limiting,
relapsing or chronic. Normally patients with IIH develop
papilledema, that if left untreated, may lead to permanent visual
loss (3–6).
By definition papilledema refers to a swelling of the optic disc
resulting from increased ICP. The development of papilledema
is thought to depend on the transmission of elevated ICP via the
subarachnoid space (SAS) to the lamina cribrosa with resulting
damage to axonal transport (7). This theory assumes a free CSF
circulation through the optic canal between the intracranial SAS
and the orbital SAS of the optic nerve.
Papilledema is usually bilateral but highly asymmetric cases
and even unilateral cases have been described (8–11). Further
there are case reports of patients that presented with persisting
papilledema after successful ICP lowering by shunt procedures
(12, 13) and there are cases of IIH without papilledema (14–16).
The understanding of the pathophysiology in patients with
IIH and persistent papilledema is of great importance as in
these patients visual impairment progresses and can result in
permanent visual loss (17, 18).
Although several studies (7, 19, 20) have demonstrated
pressure induced damage of the axonal transport in the presence
of papilledema, our knowledge about CSF dynamics along the
entire optic nerve in papilledema and it’s relationship to elevated
ICP is poor.
In the current study the contrast loaded CSF (CLCSF)
density was measured by computer tomographic (CT) assisted
cisternography at three regions along the optic nerve (orbital
optic nerve portion: bulbar segment and mid-orbital segment,
intracranial optic nerve portion) and in the basal cistern in
16 patients with history of IIH and papilledema with visual
impairment. A group of 12 patients without known history of
elevated ICP and papilledema that underwent CT cisternography
for various reasons served as controls.
This study should add to the understanding of the complex
CSF dynamics in the SAS along the entire optic nerve in patients
with IIH and papilledema.
MATERIALS AND METHODS
This study was approved by the local ethical commission
(Ethikkommission Nordwest- und Zentralschweiz) and follows
the tenets of the Declaration of Helsinki. The informed
Abbreviations: CSF, cerebrospinal fluid;IIH, idiopathic intracranial hypertension;
CT, computed tomographic; CLCSF, contrast loaded cerebrospinal fluid; HU,
Hounsfield units; ROI, regions of interest; ICP, intracranial pressure; SAS,
subarachnoid space; MRI, magnetic resonance imaging; BMI, body mass index;
MPR, multiplanar reconstruction images; MEC, meningothelial cell; VIIP, visual
impairment intracranial pressure.
consent from the subjects was checked before inclusion in this
study.
Patients With Idiopathic Intracranial
Hypertension
From 2005 to 2015 16 patients (32 optic nerves), 14 women and
2 men with an established diagnosis of IIH were admitted to
our department for CT cysternography because of a therapy-
resistant papilledema and progressive visual impairment (visual
acuity and/or visual field). Mean age was 49 ± 16 years, 47 ± 15
years in women and 68± 15 years inmen. All patients underwent
a full neuro-opthalmological examination, magnetic resonance
imaging (MRI) and lumbar puncture to establish the diagnosis.
This was based on the updated modified Dandy criteria (21).
At initially presentation all patients had bilateral papilledema
(no information about grade). The mean CSF opening pressure
measured by lumbar puncture was 40.0 ± 12.7 cmH2O (in 5
patients the lumbar CSF pressure was documented from the
performing doctor as >25 cmH2O) at time of diagnosis.
At time of cisternography in all patients both optic nerves
were involved whereas in 8 patients papilledema was slightly
asymmetrical and 2 patients showed atrophic optic discs. The
average visual field mean deviation was 6.6 ± 8.5 dB on the
right and 6.9 ± 7.9 dB on the left side using standard automated
perimetry (SAP, Program G2 Octopus Haag-Streit, Switzerland)
whereas in 5 patients only the Goldman visual field perimetry was
used. The visual acuity using the logMAR chart was 0.3 ± 0.5
right and 0.2 ± 0.3 left. The mean body mass index (BMI) was
31 ± 5. The mean CSF opening pressure measured by lumbar
puncture was 29.2 ± 8.6 cmH2O at time of cisternography
(Table 1).
Clinical symptoms were visual symptoms (blurry vision,
transient visual obscuration, visual field impairment) (16
patients), headache (12 patients), and diplopia from VIth cranial
nerve palsy (1 patient). At time of cisternography all patients
were treated with oral acetozolamide (10 patients: 1,500 mg/day,
6 patients: 1,000 mg/day due to side effects, mean dose: 1,313
mg/day) and 2 patients had additionally undergone a shunt
procedure. The duration of the therapy was variable depending
on the duration of the disease. Radiological signs showed
flattening of the posterior globe (16 patients), an “empty sella” (6
patients), and stenosis of the transverse venous sinus (3 patients).
The indication for CT cysternography was progressive visual
impairment and persistent papilledema (14 patients) or optic
nerve atrophy development (2 patients) despite weight loss
attempts and maximal therapy with systemic acetazolamide or
additionally performed shunt procedures. The mean time from
diagnosis to performed CT cisternography was highly variable
and varied between 23 years and 3 months, the mean was 5 ±
6 years.
During CT cisternography all patients were hospitalized
in our department and underwent a full ophthalmological
and neuro-ophthalmological examination including slit lamp-
assisted biomicroscopy and visual field testing.
Controls
As CT cisternography is an invasive and therefore potentially
harmful technique, a healthy aged-matched control group is
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TABLE 1 | Clinical parameters at time of cisternography of patients with Idiopathic Intracranial Hypertension (IIH).
Patients BMI Visual Acuity Visual Field CSF-p
n Age [years] kg/m² OD OS OD OS cmH2O
logMAR MD
1 60–65 36 0 0 3.9 4.3 21
2 26–30 37 0.1 0 2.8 0.7 18
3 75–80 25 1.3 0.1 25.2 25.9 24
4 56–60 38 0 0.1 1.4 9.2 26
5 20–25 24 0 0 19.4 13.7 29
6 56–60 32 0 0 0.9 0.3 34
7 20–25 33 0 0 2.1 2.7 45
8 46–50 36 0 0 2.9 2.2 34
9 46–50 33 0 1 – – 29
10 40–45 33 0 0 5.3 7.2 25
11 36–40 35 0.1 0 – – 28
12 60–65 30 1 0.5 – – 23
13 56–60 29 0.3 0.2 – – 50
14 56–60 24 0 0 2.4 2.3 34
15 30–35 27 1.3 1 – – 27
16 60–65 27 0 0 12 12.2 21
AM ± SD 49 ± 16 31 ± 5 0.3 ± 0.5 0.2 ± 0.3 6.6 ± 8.5 6.9 ± 7.9 29.2 ± 8.6
BMI, body mass index; MD, mean deviation; CSF-p, cerebrospinal fluid pressure; AM, arithmetic mean; SD, standard deviation; OD, oculus dexter (right optic nerve); OS, oculus sinister
(left optic nerve).
not available. We therefore included an inhomogeneous group
of patients who underwent CT cisternography for a variety of
indications. The same group was used as controls in a not yet
published work about glaucoma.
From the database of the Department of Neuroradiology,
Cantonal Hospital, Aarau, Switzerland, all patients who
underwent CT cisternography for various diagnostic reasons in
the period from 2010 to 2015 were used as the initial dataset. 12
patients (24 optic nerves), 9 women and 3 men without elevated
intracranial pressure (<20cmH2O) and without papilledema
were included and served as controls. Mean age was 60 ± 19
years, 61 ± 22 years in women and 55 ± 10 years in men. There
was no significant difference (p = 0.13, unpaired t-test) in age
between subjects in the IIH group and control group. Exclusion
and inclusion criteria were verified in the medical records. Six of
the controls underwent CT cisternography in order to exclude
leakage of CSF, in 4 after endonasal sinus surgery because of
chronic sinusitis and in 2 after a neurosurgery intervention
(cyst excision). In the other 6 controls CT cisternography was
performed because of neurological symptoms without cytologic
or chemical abnormalities in CSF and without pathological
findings in MRI or CT.
The mean CSF opening pressure measured by lumbar
puncture was 13.0 ± 4cmH2O (in 8 patients the lumbar CSF-p
was documented as <20cmH2O) at time of cisternography.
At the beginning of cisternography a lumbar puncture was
performed in the lateral decubitus position and CSF pressure
was measured. The patient‘s legs were straightened and the
patient was asked to remain calm and not to speak during
the measurements in order to avoid Valsalva manoeuvers. In
all patients with IIH during lumbar puncture 10ml of CSF
was sampled for biochemical analysis and then 10ml iopamidol
(molecular weight 778 D, Iopamiro 300, Bracco, Milano, Italy)
was injected intrathecally. The total CSF volume was therefore
not altered. The patient was then turned to the prone position.
The time between iopamidol injection and CT was 15min
and was the same in both patients and controls. All patients
underwent CT cisternography at the same institution, by the
same neuro-radiologist (L.R.).
A 64-detector scanner (Aquillion 64, Toshiba, Tokyo, Japan)
providing 0.5 mmX32 section collimation was used. Scanning
parameters were a 25 cmfield of viewwith a 512× 512matrix and
a soft tissue and a bone reconstruction algorithm were employed.
The field of view included the foramen magnum and the nose.
Multiplanar reconstruction images (MPR) were obtained
in the axial, coronal and sagittal planes with a 0.5mm
slice thickness. CT images were analyzed using the program
VitreaCore (Vital Images, Inc., Minnetonka, MN, USA) on
the Advantage Workstation 4.1 software (General Electric,
Milwaukee, Wisconsin, USA).
CLCSF density was measured in Hounsfield units (HU) on
CT images. Measurements of the contrast agent were performed
at three defined regions along the optic nerve and in the basal
cistern. Region of interest (ROI) 1 (bulbar segment) was defined
as the area 1–4mm in distance from the lamina cribrosa, ROI 2
(mid-orbital segment), as the area 13–16mm in distance from
lamina cribrosa and ROI 3 (intracranial portion) was defined
as the area from the optic chiasm to the cranial opening of
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the OC. ROI 4 corresponded to the basal cistern (Figure 1). In
ROI 1, ROI 2, and ROI 3 the HU measurements include also
the optic nerve because it is technically not possible to measure
the CSF filled SAS alone. The measurements in these ROIs are
therefore the “optic nerve complex density” which consists of
optic nerve sheath, CLCSF filled SAS and optic nerve tissue. The
border of the optic nerve complex was defined by the diameter
of the optic nerve sheath. Measurements were performed in
axial, sagittal and coronal sections after the images have been
formatted into a coronal plane perpendicular to the sagittal axis
of the optic nerve, in ROI 4 only the axial section was used
(Figure 2).
All CLCSF measurements were measured twice and reviewed
by an experienced neuroradiologist blinded to the neuro-
ophthalmological findings.
Statistical analysis was performed using SigmaPlot 10.0 (Systat
Software, San Jose, CA, USA), Microsoft Excel 2010 (Microsoft
Corporation, Redmond, WA, USA) for Windows statistical
package. Data were analyzed using paired or unpaired Student
t-test as appropriate to compare normally distributed variables,
and Wilcoxon Signed Rank test or Mann-Whitney U-test as
appropriate when normal distribution was not given. All data
are expressed as mean and standard deviation or median and
interquartile ranges respectively. Differences were considered
significant when the error probability was p < 0.05.
RESULTS
CT Cisternography
Bulbar Segment of Orbital Optic Nerve Portion: ROI 1
(1–4mm Distant From the Lamina Cribrosa)
In IIH patients the mean density of CLCSF measured 65
± 53 HU in the right optic nerve and 63 ± 35 HU in
the left optic nerve. In controls the mean CLCSF density
measured 226 ± 131 HU in the right optic nerve and
205 ± 111 HU in the left optic nerve (Tables 2, 3). The
FIGURE 1 | Region of interests (ROI) where contrast loaded cerebrospinal fluid
(CLCSF) density measurements were performed. ROI 1: bulbar segment of the
orbital portion, ROI 2: mid-orbital segment of the orbital portion, ROI 3:
intracranial portion, ROI 4: basal cistern.
difference between IIH patients and controls showed statistical
significance for the right and for the left side (right optic nerve:
p < 0.001, left optic nerve: p < 0.001, Mann-Whitney U-test)
(Figure 3).
Mid-Orbital Segment of Orbital Optic Nerve Portion:
ROI 2 (13–16mm Distant From the lamina cribrosa)
In IIH patients the mean CLCSF density measured 68 ± 37 HU
in the right optic nerve and 60 ± 21 HU in the left optic nerve.
In controls the mean CLCSF density measured 193 ± 82 HU in
the right optic nerve and 170 ± 61 HU in the left optic nerve
(Tables 2, 3).
The difference between IIH patients and controls showed
statistical significance for the right and for the left optic nerve
(right optic nerve: p < 0.001, left optic nerve: p < 0.001, Mann-
Whitney U-test) (Figure 3).
Intracranial Optic Nerve Portion: ROI 3 (From Optic
Chiasm to Cranial Opening of the Optic Canal)
In IIH patients themean CLCSF density measured 303± 137 HU
in the right optic nerve and 323± 169 HU in the left optic nerve.
In controls the mean CLCSF density measured 316 ± 50 HU in
the right optic nerve and 303 ± 46 HU in the left optic nerve
(Tables 2, 3). The difference between IIH patients and controls
showed neither statistical significance for the right nor for the left
optic nerve (right optic nerve: p= 0.75, unpaired t-test, left optic
nerve: p= 0.44, Mann-Whitney U-test).
Basal Cistern: ROI 4
In IIH patients the mean density of CLCSF measured 623
± 188 HU and in controls 654 ± 210 HU (Tables 2, 3).
The difference between IIH patients and controls showed no
statistical significance within the basal cystern (p = 0.69,
unpaired t-test).
CLCSF Differences Between ROIs
In IIH patients the mean difference between ROI 1 and ROI 2
(ROI 1-ROI 2)was−3HU in the right optic nerve and 3HU in the
left optic nerve. The differences were not statistically significant
(right optic nerve: p= 0.46, Wilcoxon Signed Rank test, left optic
nerve: p= 0.54, paired t-test). The mean difference between ROI
2 and ROI 3 (ROI 2-ROI 3) was−235 HU in the right optic nerve
and−264 HU in the left optic nerve. The differences were highly
statistically significant (right optic nerve: p < 0.001, paired t-
test, left optic nerve: p < 0.001, Wilcoxon Signed Rank test).
Between ROI 3 and ROI 4 (ROI 3-ROI 4) the mean difference
was−320 HU in the right optic nerve and−300 HU in the left
optic nerve. The differences were highly statistically significant
(right optic nerve: p < 0.001, paired t-test, left optic nerve:
p < 0.001, Wilcoxon Signed Rank test). The mean difference
betweenROI 1 and ROI 3 (ROI 1-ROI 3)was−238HU in the right
optic nerve and−260 HU in the left optic nerve. The differences
were highly statistically significant (right optic nerve: p < 0.001,
paired t-test, left optic nerve: p < 0.001, Wilcoxon Signed Rank
test).
In controls themean difference between ROI 1 and ROI 2 (ROI
1-ROI 2) was 33 HU in the right optic nerve and 35 HU in the
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FIGURE 2 | Contrast loaded cerebrospinal fluid (CLCSF) density measurements in the mid-orbital segment of the orbital portion (ROI 2) of a right optic nerve. Axial
(A,B), sagittal (C,D), and coronal (E,F) sections were used.
TABLE 2 | Measurements of contrast loaded cerebrospinal fluid (CLCSF) along the entire optic nerve in patients with Idiopathic Intracranial Hypertension (IIH).
Patients Basal cistern Intracranial portion Mid-orbital segment Bulbar segment
[ROI 4] [ROI 3] [ROI 2] [ROI 1]
n Age OD OS OD OS OD OS
Years HU HU HU HU
1 60–65 542 203 205 62 47 43 39
2 26–30 701 231 287 127 78 233 118
3 75–80 1070 689 769 33 42 40 40
4 56–60 820 492 317 74 75 81 86
5 20–25 488 247 243 41 20 30 28
6 56–60 529 240 235 175 71 47 59
7 20–25 642 305 318 65 92 33 101
8 46–50 433 152 138 40 35 29 29
9 46–50 382 377 601 79 54 121 84
10 40–45 515 203 211 82 77 105 101
11 36–40 635 222 262 45 91 47 131
12 60–65 578 319 323 52 50 37 35
13 56–60 448 206 183 39 31 32 32
14 56–60 791 350 350 58 65 43 45
15 30–35 895 402 520 46 72 43 50
16 60–65 520 207 209 73 54 76 29
AM ± SD 49 ± 16 623 ± 188 303 ± 137 323 ± 169 68 ± 37 60 ± 21 65 ± 53 63 ± 35
HU, Hounsfield units; ROI, region of interest; AM, arithmetic mean; SD, standard deviation; OD, oculus dexter (right optic nerve); OS, oculus sinister (left optic nerve).
left optic nerve. The differences were not statistically significant
(right optic nerve: p = 0.38, Wilcoxon Signed Rank test, left
optic nerve: p= 0.16, paired t-test). The mean difference between
ROI 2 and ROI 3 (ROI 2-ROI 3) was−123 HU in the right optic
nerve and−133 HU in the left optic nerve. The differences were
highly statistically significant (right optic nerve: p < 0.001, left
optic nerve: p < 0.001, paired t-test). Between ROI 3 and ROI
4 (ROI 3-ROI 4) the mean difference was−338 HU in the right
optic nerve and−351 HU in the left optic nerve. The differences
were highly statistically significant (right optic nerve: p < 0.001,
left optic nerve: p < 0.001, paired t-test). The mean difference
between ROI 1 and ROI 3 (ROI 1-ROI 3) was−90 HU in the right
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TABLE 3 | Measurements of contrast loaded cerebrospinal fluid (CLCSF) along the entire optic nerve in controls without elevated intracranial pressure and without
papilledema.
Controls Basal cistern Intracranial portion Mid-orbital segment Bulbar segment
[ROI 4] [ROI 3] [ROI 2] [ROI 1]
n Age OD OS OD OS OD OS
Years HU HU HU HU
1 90–95 1,067 268 230 278 151 246 242
2 40–45 607 307 312 83 100 116 166
3 46–50 881 239 206 202 180 229 141
4 30–35 595 268 299 90 84 110 149
5 30–35 807 393 331 116 115 126 146
6 66–70 500 316 308 147 109 145 127
7 76–80 368 374 327 202 200 131 131
8 66–70 527 306 350 144 188 176 168
9 46–50 860 270 335 295 289 575 529
10 70–75 391 321 299 246 202 273 185
11 76–80 610 379 359 180 185 315 208
12 46–50 639 353 284 337 234 268 266
AM ± SD 60 ± 19 654 ± 210 316 ± 50 303 ± 46 193 ± 82 170 ± 61 226 ± 131 205 ± 111
HU, Hounsfield units; ROI, region of interest; AM, arithmetic mean; SD, standard deviation; OD, oculus dexter (right optic nerve); OS, oculus sinister (left optic nerve).
optic nerve and−98 HU in the left optic nerve. The differences
were slightly statistically significant (right optic nerve: p = 0.06,
paired t-test, left optic nerve: p = 0.034, Wilcoxon Signed Rank
test).
The difference of CLCSF density between the right and the left
optic nerve was not statistically significant in either group (IIH:
ROI 1: p= 0.96,Mann-WhitneyU-test; ROI 2: p= 0.43, unpaired
t-test; ROI 3: p = 0.81, Mann-Whitney U-test; controls: ROI 1:
p= 0.89,Mann-WhitneyU-test; ROI 2: p= 0.43, ROI 3: p= 0.52;
unpaired t-test).
DISCUSSION
The current study uses CT cisternography to assess the CSF
dynamics along the entire optic nerve in 16 patients with a history
of IIH and papilledema and in 12 controls without elevated
ICP and without papilledema. The measurements demonstrate
a significant reduction of CLCSF concentrations within the
intraorbital optic nerve segments in patients with IIH compared
to controls.
The CSF pathway within the SAS of optic nerve is a closed
circulatory system that ends behind the eye ball. CSF moves
from the basal cistern to the intracranial optic nerve portion
and then via the optic canal into the intraorbital segments (mid-
orbital segment and retrobulbar segment) to the lamina cribrosa
at the posterior end of the globe. Both the SAS diameter and
the meshwork of trabeculae and septae that bridge the SAS
differ in number and morphology within the different optic
nerve portions. The narrowest diameter is measured within the
intracanalicular portion where the SAS is confined by bone
(7, 22–24).
Cisternography is at present the only method that can provide
information on CSF flow dynamics in the SAS of the optic nerve
in vivo. In accordance with the second law of thermodynamics
a homogenous distribution of CLCSF is expected after
injection of contrast agent into the CSF. The measurements
of CLCSF along the entire optic nerve in the present study
however clearly demonstrate a reduced CLCSF density in
the orbital optic nerve segments in patients with IIH and
papilledema.
The highest CLCSF density was measured in both IIH patients
and controls in the basal cistern (ROI 4). This is not surprising
as the volume of the chiasmal cistern is much larger than the
SAS volume surrounding the optic nerve. Further, the density
measured in the basal cistern is biased by the measurement
method used.Wemeasured the CLCSF as themean of HUwithin
a circle because CT imaging does not allow us to distinguish the
exact borders of the optic nerve and the optic nerve sheath. The
density measurements along the optic nerve therefore include the
optic nerve sheath and the optic nerve itself which is not filled
with CSF and is therefore lower than that in the basal cistern
where the optic nerve density does not bias the measurement.
In both IIH patients and controls a significant reduction of
CLCSF density was measured between the intracranial (ROI
3) and the mid-orbital segment of the orbital optic nerve
portion (ROI 2). In controls the measured CLCSF density
reduction through the optic canal is most likely to be due
to the physiological diminution of the SAS diameter within
the intracanalicular optic nerve portion. The SAS measured its
smallest diameter within the optic canal (7, 22, 23) where the
arachnoid and pia mater are merged (24). A reduced volume of
CSF within the optic canal is therefore the normal condition. The
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FIGURE 3 | Scatterplot of contrast loaded cerebrospinal fluid (CLCSF) density measurements in Hounsfield Units (HU) in the bulbar- (ROI 1) and mid-orbital segment
(ROI 2) of the optic nerve, the intracranial portion (ROI 3) of the optic nerve and in the basal cistern (ROI 4) in patients with idiopathic intracranial hypertension (IIH) and
papilledema and controls, separated for right and left optic nerve. IIH patients (n = 16) and controls (n = 12). •, IIH patients; ◦, controls; OD, oculus dexter (right optic
nerve); OS, oculus sinister (left optic nerve).
gradient of CLCSF however was significantly higher in patients
with IIH (right optic nerve: −235 HU, left optic nerve: −264
HU) compared to controls (right optic nerve: −123 HU, left
optic nerve: −133 HU). While CLCSF density measurements
were similar within the basal cistern (ROI 4) and the intracranial
optic nerve portion (ROI 3) in IIH patients and controls (ROI 4:
623 HU vs. 654 HU; ROI 3: right optic nerve: 303 HU vs. 316
HU, left optic nerve = 323 HU vs. 303 HU), a highly statistically
significant reduction was measured within the intraorbital optic
nerve segments in patients with IIH (ROI 2: right optic nerve:
68 HU vs. 193 HU, left optic nerve: 60 HU vs. 170 HU; ROI 1:
right optic nerve: 65 HU vs. 226 HU, left optic nerve: 63 HU vs.
205 HU). In controls CLCSF passes the optic canal and flows into
the mid-orbital segment with a small peak in the bulbar segment
behind the lamina cribrosa (ROI 1). In contrast to patients with
IIH the CLCSF inflow into the orbital optic nerve SAS almost
stops at the canalicular optic nerve portion and very little CLCSF
reaches the bulbar segment behind the lamina cribrosa (ROI 1)
(Figures 4, 5).
Evidence for the restricting effect of the optic canal on
CSF dynamics in patients with IIH was provided by pro–and
retrospective clinical studies (25, 26). Bidot et al. (25) investigated
in a retrospective review of magnetic resonance images (MRI) the
optic canal size and the severity of papilledema in 69 patients
with IIH. Their measurements showed an association between
the optic canal size and the severity of papilledema. More severe
papilledema and poorer visual function were associated with
a larger optic canal area. Accordingly, the side of less severe
papilledema in 8 patients with asymmetric papilledema was
associated with a smaller optic canal area (9). In a prospective
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FIGURE 4 | Distribution of contrast loaded cerebrospinal fluid (CLCSF) along the entire optic nerve in patients with idiopathic intracranial hypertension (IIH) and
papilledema and controls, separated for right and left optic nerve. ROI 1: bulbar segment of the orbital portion, ROI 2: mid-orbital segment of the orbital portion, ROI 3:
intracranial portion. •, IIH patients; ◦, controls.
FIGURE 5 | Computed tomographic (CT) cisternography in a patient with idiopathic intracranial hypertension (IIH) and papilledema and a control subject. In the
patient with IIH (A,B) contrast loaded cerebrospinal fluid (CLCSF) inflow stops behind the optic canal while in the control subject (C,D) contrast loaded cerebrospinal
fluid (CLCSF) flows into the orbital segment to the globe.
study of 54 patients with intracranial pressure measurement and
600 controls (26) measured the optic canal on CT scans. This
study explains why optic nerve sheath diameter monitoring may
provide false-negative results in cases with narrow optic canals.
In such cases there will be reduced CSF inflow into the SAS of the
optic nerve causing a false negative smaller optic nerve sheath
diameter.
The optic canal is confined by bone and the meninges.
While bone represents the solid component, the structure of
the meninges is more dynamic. The meningothelial cell (MEC)
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layer that forms the arachnoid and the pia layer of the meninges
therefore play an important role for the anatomy of the optic
canal. MECs are multifunctional cells that cover the pia and the
arachnoid layer of the meninges in the entire central nervous
system and thus the septae and trabeculae in the SAS of the
optic nerve (22). MECs have been shown to react with growth
and proliferation to mechanical stimuli such as pressure (27).
Elevation of ICP in patients with IIH will therefore particularly
stimulate MECs proliferation. This leads to obstruction and
compartmentation of the SAS which is most crucial within
the narrow SAS of the intracanalicular optic nerve portion.
The “bottleneck” like characteristic of the optic canal might be
particularly crucial in patients with elevated ICP and influence
CSF dynamics along the optic nerve as measured in the curr]ent
study. A similar finding has recently found in patients with
normal tension glaucoma (28).
Such impaired CSF dynamics within the orbital optic nerve
segments might be of clinical importance. Once CSF influx
stagnates, the SAS of the optic nerve turns into a CSF
compartment with a reduced in and outflow of CSF. This
results in an accumulation of biologically active substances,
such as L-PGDS, a multifactorial prostaglandin synthetase. CSF
sampling during optic nerve sheath fenestration in patients with
papilledema demonstrated exceedingly high concentrations of
this protein (29). Recent research points to the neurotoxic effect
of L-PGDS (30). Impaired CSF turnover adjacent to the optic
nerve head will result in accumulation of toxic substances and
reduced clearance of CSF. This may lead to neuronal, axonal and
glial cell damage which may result in the clinical manifestation
we observe in patients with IIH and papilledema.
Changes in the optic canal patency and formation of an optic
nerve sheath compartment have also recently been considered
to play a role in the development of the visual impairment
intracranial pressure (VIIP) syndrome found in astronauts after
prolonged space flight (31).
The present study further might be of interest for the
treatment options in patients with IIH and persisting papilledema
in spite of normalized ICP (12, 13). Given that an optic
nerve sheath compartment has developed, optic nerve sheath
fenestration that releases the local damaging pressure to the optic
nerve, might be superior to a shunt procedure.
There are several obvious weaknesses in this study which
need to be addressed. Firstly, the large differences in time from
first diagnosis to cisternography and thus the differences in the
duration of the disease in IIH patients. As cisternography is
not a primary procedure in patients with IIH, cisternography
was only performed in IIH patients with persistent papilledema
and progressive visual impairment despite loss weight attempts
and maximal therapy with systemic acetazolamide and or
ventriculoperitoneal shunt surgery. The IIH patients in this
study does therefore not present the “typical IIH patient.”
The patients are not within the typically age range and the
BMI is lower compared to the typical IIH cohort. If this
is due to a cultural difference between different populations
(Swiss with other countries) needs further studies. Secondly, the
control group is not homogeneous and the controls underwent
cisternography for various indications. Due to the invasive nature
of cisternography we cannot, for obvious ethical considerations,
provide a healthy aged- and gender matched control group of
“normal.” However, the differences between IIH patients and
the control group is clearly demonstrated. Thirdly, the density
measurements in ROI 1, ROI 2, and ROI 3 are biased by including
the optic nerve itself because it is still technically not possible
for us to measure the CSF filled SAS alone. This however is
the case in both groups and does therefore not compromise the
comparison between controls and IIH. Fourthly, the number of
patients in both the IIH- and the control group is rather small
(IIH: n= 16, controls: n= 12) and lastly, the retrospective nature
of the current study.
The current study demonstrates reduced CLCSF density
within the orbital optic nerve segments in 16 (32 optic nerve)
patients with history of IIH and papilledema. It is possible that
impaired CSF dynamics are involved in the pathophysiology of
IIH.
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